维多利祖马布在克罗恩病中实现全肠粘膜愈合:一项前性观察性研究
Offir Ukashi1, Adi Lahat1,2, Bella Ungar1
1Sheba Medical Center Tel Hashomer, Faculty of Medical and Health Sciences, Gastroenterology Institute, Tel-Aviv University, Tel Aviv, Israel.
United European gastroenterology journal
|September 7, 2025
概括
维多利祖马布治疗显著改善了克罗恩氏病 (CD) 患者的粘膜愈合 (MH),在52周内实现了全肠MH (PE-MH) 和小肠MH (SB-MH). 这证明了 vedolizumab 的存在.
科学领域:
- 胃肠病学 胃肠病学
- 炎症性肠道疾病研究研究
- 临床治疗学 临床治疗学
背景情况:
- 粘膜愈合 (MH) 是克罗恩病 (CD) 的一个关键治疗目标.
- 有限的数据存在于全肠道MH (PE-MH) 与CD中的vedolizumab.
- 本研究评估了使用囊内镜对PE-MH的vedolizumab的疗效.
研究的目的:
- 评估vedolizumab在在CD患者中实现PE-MH的有效性.
- 评估vedolizumab对小肠MH (SB-MH) 和结肠MH的影响.
- 为了将内镜治疗与生化标志物相关联.
主要方法:
- 在44名CD患者的前性,开放性观察性研究中,开始使用vedolizumab.
- 在基线,14周和52周使用PillCam克罗恩氏囊,C反应蛋白 (CRP) 和便calprotectin (FCP).
- 定义PE-MH为SB-路易斯得分 (LS) <135和结肠-伊利亚基姆得分 (ES) =0.
主要成果:
- 在52周,15.9%的患者实现了PE-MH (p=0.016).
- 在第52周,SB-MH比率从基线显著增加到18.2% (p<0.001).
- 观察到FCP,LS和ES的显著减少,其中31.8%的人实现了生化缓解.
结论:
- 维多利祖马布治疗在CD患者中促进了显著的生化和内镜改善.
- 在52周内实现了显著的SB-MH和PE-MH率.
- 支持vedolizumab作为一种有效的疗法,用于诱导CD的粘膜愈合.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Inflammatory Bowel Disease IV: Pharmacological Management
531
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
531
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
506
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
506
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
Inflammatory Bowel Disease II: Crohn's Disease
961
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
961


